Related Experiment Videos
[Current therapy of ulcer disease].
1Abteilung Gastroenterologie, Allgemeinen Krankenhauses Celle, Deutschland.
Wiener Medizinische Wochenschrift (1946)
|January 1, 1992
Summary
Modern ulcer therapy focuses on reducing gastric acid to heal and prevent gastrointestinal ulcers. Effective treatments like H2-blockers and Omeprazole significantly lower relapse rates and improve patient quality of life.
Area of Science:
- Gastroenterology and Pharmacology
- Mucosal defense mechanisms
- Pathophysiology of ulcer disease
Context:
- Ulcer pathogenesis involves an imbalance between aggressive factors (gastric acid, pepsin) and mucosal defense defects.
- Current pharmacological interventions cannot fully substitute impaired mucosal defense mechanisms.
- Modern ulcer therapy prioritizes significant acid reduction.
Purpose:
- To review the pathophysiological and pharmacological basis of medical ulcer therapy.
- To provide guidelines for the indication and application of anti-ulcer drugs.
- To discuss short-term and long-term treatment strategies for gastrointestinal ulcers.
Summary:
- Acid reduction is the cornerstone of effective ulcer therapy, with drug potency correlating directly to efficacy (maintaining pH > 3).
- Long-term treatment with H2-blockers and Omeprazole (an ATPase inhibitor) drastically reduces ulcer relapse rates and enhances quality of life.
- Effective prophylaxis for duodenal ulcers can be achieved with combination therapies, including bismuth plus antibiotics or Omeprazole plus antibiotics.
- Acid-reducing drugs are effective in treating and preventing ulcers induced by nonsteroidal anti-inflammatory drugs (NSAIDs) or acetylsalicylate.
Impact:
- Significant reduction in gastrointestinal ulcer relapse rates.
- Marked improvement in the quality of life for patients with ulcer disease.
- Provides a comprehensive guide for clinicians on managing ulcer therapy.